The aim of this study was to examine relationship between dietary carbohydrate, glycemic index, glycemic load and gastric cancer risk. This hospital based case-control study was conducted in Nis (Serbia) between 2005 and 2006. Subjects (n=102) with histologically confirmed gastric cancer and controls (n=204) selected from non-cancer patients were interviewed. The structured questionnaire included information on socio-demographic and lifestyle habits. Data from dietary habits were based on Food Frequency Questionnaire (FFQ). We found reductions in gastric cancer risk for diets high in carbohydrate (OR for highest versus the lowest tertile = 0.07, 95% CI: 0.02-0.23) and mono- and disaccharides (OR = 0.03, 95% CI: 0.01-0.09) and increased risk (OR = 4.13, 95% CI: 1.73-9.86) for high polysaccharide intake. Total carbohydrate intake (OR = 0.17, 95% CI: 0.04-0.66) and mono- and disaccharides intake (OR = 0.06, 95% CI: 0.02-0.20) was associated with a reduction in gastric cancer risk, while polysaccharide intake was associated with an increased risk (OR = 4.85, 95% CI: 1.67-14.09) for the diffuse type only. In both histological subtypes, there was not significant association between glycemic index, glycemic load and the risk of gastric cancer. Our results suggest that increased intake of foods rich in carbohydrate, particularly mono- and disaccharides, as well as reduced consumption of food rich in polysaccharides, may lower the risk of diffuse type of gastric cancer. Our data do not support association between glycemic index, glycemic load and the risk of gastric cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.21101/cejph.a3501 | DOI Listing |
BMC Cancer
January 2025
Patient Centered Solutions, IQVIA, Reading, UK.
Background: Despite approvals of new first-line immunotherapies for advanced/metastatic gastric cancer/gastroesophageal junction cancer (aGC/GEJC), patients' median survival is around 14 months and their health-related quality of life (HRQoL) is affected by disease-related symptoms and treatment-related side effects. Using a targeted literature review (TLR) and patient interviews, this study identified disease- and treatment-related concepts that are important to patients with aGC/GEJC and their HRQoL.
Methods: A TLR was conducted to identify primary qualitative studies from 2018 to 2021 on patients' experiences with aGC/GEJC.
J Gastroenterol
January 2025
Faculty of Information Science and Technology, Hokkaido University, Sapporo, Japan.
Background: The automated classification of Helicobacter pylori infection status is gaining attention, distinguishing among uninfected (no history of H. pylori infection), current infection, and post-eradication. However, this classification has relatively low performance, primarily due to the intricate nature of the task.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
January 2025
Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Purpose: To evaluate the added value of additional Ga-FAPI PET/CT following CT for primary staging, detection of postoperative recurrence, and management of gastric cancer patients.
Methods: We retrospectively included patients with gastric cancers who underwent contrast-enhanced computed tomography (ceCT), followed by Ga-FAPI PET/CT within 30 days. Ga-FAPI PET/CT was performed for initial staging or detection of postoperative recurrence.
Clin Nutr ESPEN
January 2025
The Affiliated Hospital of Qingdao University, Qingdao 266001, Shandong province, China. Electronic address:
Background: Esophagojejunal anastomotic fistula (EJF) following radical total gastrectomy is a severe perioperative complication in patients with gastric cancer, particularly as delayed fistula healing increases hospitalization costs and leads to poor prognosis. Numerous factors influence the occurrence and progression of EJF, with inflammation and nutritional status being significant contributors to perioperative complications. Therefore, this study aims to investigate the prediction of delayed EJF healing based on postoperative clinical and imaging-related inflammation-nutrition status.
View Article and Find Full Text PDFJNCI Cancer Spectr
January 2025
Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
Since the early 1990s, there has been a dramatic rise in gastrointestinal cancers diagnosed in patients under age 50 for reasons that remain poorly understood. The most significant change has been the increase in incidence rates of early-onset colorectal cancer, especially rates of left-sided colon and rectal cancers. Increases in gastric, pancreatic, and other gastrointestinal cancer diagnoses have further contributed to this trend.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!